In the context of cancer, transcriptomics can reveal significant insights into the molecular mechanisms that drive cancer development and progression. By comparing the transcriptome of cancerous cells to that of normal cells, researchers can identify differentially expressed genes that may serve as biomarkers or therapeutic targets.
